A prospective study of calcaneal bone mineral density in acute charcot osteoarthropathy

Diabetes Care

Volumn 33, Issue 10, 2010, Pages 2254-2256

  Petrova, Nina L ^a   Edmonds, Michael E ^a  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE CHARCOAT OSTEOARTHROPATHY; ADULT; ARTICLE; BONE DENSITY; CALCANEUS; CAST APPLICATION; CHARCOT FOOT; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC FOOT; DIABETIC PATIENT; DISEASE ASSOCIATION; FEMALE; FOOT; FOOT DISEASE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MALE; NEUROPATHIC JOINT DISEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; PROSPECTIVE STUDY; QUANTITATIVE ANALYSIS; TREATMENT DURATION; TREATMENT OUTCOME; ULTRASOUND;

ARTHROPATHY, NEUROGENIC; BONE DENSITY; CALCANEUS; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC FOOT; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES;

EID: 79951716002     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc10-0636     Document Type: Article

References (11)

1. Petrova NL, Foster AV, Edmonds ME. Calcaneal bone mineral density in patients with Charcot neuropathic osteoarthropathy: differences between Type 1 and Type 2 diabetes. Diabet Med 2005;22:756-761 (Pubitemid 40805898)
2. Young MJ, Marshall A, Adams JE, Selby PL, Boulton AJ. Osteopenia, neurological dysfunction, and the development of Charcot neuroarthropathy. Diabetes Care 1995;18:34-38
3. Jirkovská A, Kasalický P, Boucek P, Hosová J, Skibová J, Kasalicky P, Boucek P, Hosova J, Skibova J. Calcaneal ultrasonometry in patients with Charcot osteoarthropathy and its relationship with densitometry in the lumbar spine and femoral neck and with markers of bone turnover. Diabet Med 2001;18:495-500 (Pubitemid 32738700)
4. Sinacore DR, Hastings MK, Bohnert KL, Fielder FA, Villareal DT, Blair VP 3rd, Johnson JE. Inflammatory osteolysis in diabetic neuropathic (charcot) arthropathies of the foot. Phys Ther 2008;88:1399-1407
5. Armstrong DG, Lavery LA, Liswood PJ, Todd WF, Tredwell JA. Infrared dermal thermometry for the high-risk diabetic foot. Phys Ther 1997;77:169-175
6. Petrova NL, Edmonds ME. Charcot neuro-osteoarthropathy: current standards. Diabete Metab Res Rev 2008;24(Suppl. 1):S58-S61
7. Jeffcoate WJ, Game F, Cavanagh PR. The role of proinflammatory cytokines in the cause of neuropathic osteoarthropathy (acute Charcot foot) in diabetes. Lancet 2005;366:2058-2061 (Pubitemid 41773381)
8. Jeffcoate WJ. Abnormalities of vasomotor regulation in the pathogenesis of the acute charcot foot of diabetes mellitus. Int J Low Extrem Wounds 2005;4:133-137 (Pubitemid 41437579)
9. Petrova NL, Dew T, Musto R, Langworthy R, Sherwood R, Moniz C, Edmonds ME. The proinflammatory cytokines, TNF-alpha and IL-6, are linked with pathological bone turnover in the acute Charcot foot (Abstract). Diabet Med 2008;25:A22
10. Hastings MK, Sinacore DR, Fielder FA, Johnson JE. Bone mineral density during total contact cast immobilization for a patient with neuropathic (Charcot) arthropathy. Phys Ther 2005;85:249-256 (Pubitemid 40333544)
11. Langton CM, Palmer SB, Porter RW. The measurement of broadband ultrasonic attenuation in cancellous bone. Eng Med 1984;13:89-91 (Pubitemid 14050856)